[Special Stock] Samchundang Pharmaceutical Hits Upper Limit... Exclusive US Sales Contract with German Company

Samchundang Pharmaceutical has hit the upper price limit.

As of 10:48 AM on the 23rd, Samchundang Pharmaceutical was trading at 153,500 KRW on the KOSDAQ market, up 35,400 KRW (29.97%) from the previous trading day.

Samchundang Pharmaceutical recorded the upper price limit following news that it signed an exclusive sales contract with a German company for the Ailia biosimilar candidate substance in the United States and Central and South American countries.